Aptevo Therapeutics
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. They leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients.Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a result, Aptevo has been able to attract some of the most innovative minds in the field. Many of our team members have notable experience with other pioneering biotech companies including Trubion, ZymoGenetics, Immunex, Dendreon, and VLST.
Domain
aptevotherapeutics.com
Country
United StatesIndustry
BiometricsEmployees
11-50
Last Funding
$60.0M
Founded
2015
Tech Stack (18 technologies)
Frequently Asked Questions
What technologies does Aptevo Therapeutics use?+
Aptevo Therapeutics uses 18 technologies including Modernizr, prettyPhoto, WordPress.
What industry is Aptevo Therapeutics in?+
Aptevo Therapeutics operates in the Biometrics industry.
Where is Aptevo Therapeutics based?+
Aptevo Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026